SEATTLE, Feb. 8 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today
that Robert Kirkman, M.D., President and Chief Executive Officer, will
present at the 13th Annual BIO CEO & Investor Conference in New York on Tuesday, February
15, 2011, at 1:00 p.m. Eastern Time.
A live and archived webcast of Dr. Kirkman's presentation will be
accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon's goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
For further information:
Investor and Media Relations Contact: